Kotaro Shikano
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Long-Term Effectiveness and Safety of Denosumab for Osteoporosis in Patients With Rheumatic Diseases.
Journal: The Journal of rheumatology
Published: May 20, 2025
Effectiveness of Daily Teriparatide in Managing Glucocorticoid-Induced Osteoporosis in Rheumatic Disease Patients After Switching From Bisphosphonate Therapy.
Journal: Cureus
Published: April 17, 2025
Efficacy of Denosumab for Osteoporosis in Patients with Rheumatic Diseases.
Journal: Internal medicine (Tokyo, Japan)
Published: August 14, 2022
Efficacy of mycophenolate mofetil in Japanese patients with systemic lupus erythematosus.
Journal: Clinical rheumatology
Published: December 19, 2018
Glucocorticoid therapy causes contradictory changes of serum Wnt signaling-related molecules in systemic autoimmune diseases.
Journal: Clinical rheumatology
Published: March 14, 2017
Apparent Hypothalamic-Pituitary-Adrenal Axis Suppression via Reduction of Interleukin-6 by Glucocorticoid Therapy in Systemic Autoimmune Diseases.
Journal: PloS one
Published: August 18, 2016
Efficacy of Vitamin K2 for Glucocorticoid-induced Osteoporosis in Patients with Systemic Autoimmune Diseases.
Journal: Internal medicine (Tokyo, Japan)
Published: August 02, 2016
Folylpolyglutamate synthase is a major determinant of intracellular methotrexate polyglutamates in patients with rheumatoid arthritis.
Journal: Scientific reports
Published: June 15, 2016
The growth factor midkine may play a pathophysiological role in rheumatoid arthritis.
Journal: Modern rheumatology
Published: May 11, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026